Pharma Journalist -

Portola Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of the Company’s Prior Approval Supplement (PAS) filing for the…
Read More...

WuXi Biologics and Inhibrx announced that the companies have entered into an exclusive partnership for the GMP manufacturing of certain of Inhibrx's protein-based therapeutics. The…
Read More...

Eyevance Pharmaceuticals announced the acquisition of FRESHKOTE - a family of lubricant eye drops from Focus Laboratories, Inc. Under the terms of the agreement, Eyevance acquired…
Read More...

Global alternative asset manager The Carlyle Group announced that it has acquired a significant minority stake in Ambio Holdings, Inc., a fast-growing global peptide active…
Read More...

SMi Reports: This year’s Orphan Drugs & Rare Diseases Conference Chair Carina Schey, Researcher at University of Groningen, has released a letter of invitation detailing the 8th…
Read More...

TECHNOLOGY AND INNOVATION DRIVES THE SUCCESS OF MEDICAL FAIR ASIA & MEDICAL MANUFACTURING ASIA 2018 The two exhibitions welcomed over 20,000 visitors from around the world…
Read More...

BioCryst Pharmaceuticals announced that the Centers for Disease Control and Prevention (CDC) has awarded BioCryst a $34.7 million contract for the procurement of up to 50,000 doses of…
Read More...

Scilex Pharmaceuticals Inc. (Scilex), a subsidiary of Sorrento Therapeutics, Inc. announced data showing ZTlido (lidocaine topical system) 1.8% (ZTlido) demonstrated a statistically…
Read More...

Thermo Fisher Scientific has signed a definitive agreement with BD (Becton, Dickinson and Company) under which Thermo Fisher will acquire BD's Advanced Bioprocessing business. This…
Read More...

AstraZeneca and its partner Amgen Inc. announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for tezepelumab in patients with severe…
Read More...